Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects
Authors
Keywords
-
Journal
BRAIN
Volume 139, Issue 6, Pages 1700-1712
Publisher
Oxford University Press (OUP)
Online
2016-03-27
DOI
10.1093/brain/aww062
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy
- (2016) Jérôme J. Devaux et al. NEUROLOGY
- Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia
- (2015) Yumako Miura et al. BRAIN
- The expanding field of IgG4-mediated neurological autoimmune disorders
- (2015) M. G. Huijbers et al. EUROPEAN JOURNAL OF NEUROLOGY
- Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies
- (2015) Kathrin Doppler et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
- (2015) Emily K Mathey et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies
- (2014) Jia Pei Lim et al. AUTOIMMUNITY REVIEWS
- Specific ContactinN-Glycans Are Implicated in Neurofascin Binding and Autoimmune Targeting in Peripheral Neuropathies
- (2014) Marilyne Labasque et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg
- (2014) L. Querol et al. NEUROLOGY
- Neurofascin 186 specific autoantibodies induce axonal injury and exacerbate disease severity in experimental autoimmune encephalomyelitis
- (2013) Maren Lindner et al. EXPERIMENTAL NEUROLOGY
- MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
- (2013) M. G. Huijbers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases
- (2013) Catherine Faivre-Sarrailh et al. Frontiers in Cellular Neuroscience
- Antibodies to Gliomedin Cause Peripheral Demyelinating Neuropathy and the Dismantling of the Nodes of Ranvier
- (2012) Jérôme J. Devaux AMERICAN JOURNAL OF PATHOLOGY
- Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy
- (2012) Luis Querol et al. ANNALS OF NEUROLOGY
- Neurofascin as a target for autoantibodies in peripheral neuropathies
- (2012) J. K. M. Ng et al. NEUROLOGY
- Advances in the diagnosis, pathogenesis and treatment of CIDP
- (2011) Marinos C. Dalakas Nature Reviews Neurology
- Permeability of the Paranodal Junction of Myelinated Nerve Fibers
- (2010) A. Mierzwa et al. JOURNAL OF NEUROSCIENCE
- Multiple functions of the paranodal junction of myelinated nerve fibers
- (2009) Jack Rosenbluth JOURNAL OF NEUROSCIENCE RESEARCH
- Spatiotemporal ablation of myelinating glia-specificneurofascin(NfascNF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains
- (2009) Anilkumar M. Pillai et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis
- (2008) Aurélie Lonigro et al. BRAIN
- Glial and neuronal isoforms of Neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system
- (2008) Barbara Zonta et al. JOURNAL OF CELL BIOLOGY
- Tight junctions potentiate the insulative properties of small CNS myelinated axons
- (2008) Jerome Devaux et al. JOURNAL OF CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now